ãã¹ãŠã¯ææç ã®éæ³æ¥åã ã£ã
ãäºã®å§ãŸãã¯äºå¹Žåã
ææç ãçºè¡šããã¯ã¯ãã³å¹æã®è«æã«å¯ŸããŠããã®æ ¹æ ã®ããŒã¿ã¯äœã§ããïŒãšã¡ãŒã«ã§è³ªåãããããå人ã®è³ªåã«ã¯ãçãã§ããŸããããšãã察å¿ããããããšããèªåã®ã¯ã¯ãã³æ
å ±éç€ºã®æ¢æ±ãå§ãŸã£ãã®ã§ããã
ãäžèšè«æã®ã¯ã¯ãã³å¹æã®æ ¹æ è³æã«å¯ŸããŠã¯ããŸã 審æ»è«æ±ãç¶ããŠããç¶æ
ã§ãããéäžçµéã§ãæãã¹ãäºå®ãæããã«ãªã£ãŠããŸãã
ææç ã®ã¯ã¯ãã³æ¥åå
šäœã«å¯ŸããŠã®éæ³æ§ã瀺ãããšã«ãªããŸãã
ä»åã¯ãã®éäžçµéããäŒãããŸãã
âªæŠç¥â«
2021幎8æãææç ãã¯ã¯ãã³å¹æãèšèŒããè«æãçºè¡šããŠããããã®ããŒã¿ãç°åžžã«é«ãã¯ã¯ãã³æå¹æ§ã瀺ããŠããã®ã§ãã®æ ¹æ è³æãæ
å ±é瀺ãããäžé瀺決å®ãããããååŽçãžå¯©æ»è«æ±ãããããæãã¹ãçããåŸ
ã£ãŠãããããã玹ä»ã
ãŸãã¯ææç ã®è«æ
ã¯ã¯ãã³ã®æ®åã«äŒŽããèŠå®åæ°ã®ã¯ã¯ãã³æ¥çš®ãâŸã£ãŠã SARS-CoV-2 ã«ææããããããããã¬ã€ã¯ã¹ã«ãŒææã泚✬ãããŠããŸããã€ã¹ã©ãšã«ã§ã¯ãå šåœçãªã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ã宿œãããŸããããã€ã¹ã©ãšã«ã® 16 æ³ä»¥äžâŒâŒã®ãã¡ 7 å²ä»¥äžããã¡ã€ã¶ãŒè£œã¯ã¯ãã³ 2 åæ¥çš®å®äºããæ®µéïŒ4 ✠3 âœãŸã§ïŒã§ãã€ã¹ã©ãšã«ä¿å¥ççãâŸã£ãæ€èšã«ãããšãã¯ã¯ãã³æ¥çš®åŸææäŸã¯ãããã®ã®ãCOVID-19 é¢é£âŒé¢ãäºé²ããã¯ã¯ãã³ã®æå¹æ§ïŒvaccine effectiveness; VEïŒã¯ 98.0%ïŒ95%ä¿¡é Œåºé[CI], 97.7-98.3%ïŒãéç/æéç COVID-19 ã«ããâŒé¢ãäºé²ãã VE 㯠98.4%ïŒ95%CI, 98.1-98.6%ïŒã
COVID-19 é¢é£æ»äº¡ãäºé²ãã VE 㯠98.1%ïŒ95%CI, 97.6-98.5%ïŒãšãããã⟌ãå ±åãããŠããŸã(1)ã
ã€ã¹ã©ãšã«ã®éçåäºé²çãã2021幎8æã§98ïŒ
ãšããŠããŸããããã®ææã€ã¹ã©ãšã«ä¿å¥çã®çºè¡šã§ã¯ãã§ã«éçåäºé²ãäœäžããŠããããšãèšäºã«åºãŠãããææç ã®è«æã®æé ãçãããããã§ãã
7æ4æ¥ã®æç¹ã§åœæ°ã®78ïŒ ãæ¥çš®ãçµããäžçã§ãæãææäºé²ãé²ãã§ãããšèŠãããŠããã€ã¹ã©ãšã«ã7æãã8æç¬¬1é±ã«ãããŠãã³ããã®é節æ£è ãæ¥æ¡å€§ããŠããããã ã
ãã®ãããã¢ã¡ãªã«ã®CDCïŒçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒã§ã¯ãåœæ°ã«å¯ŸããŠãã€ã¹ã©ãšã«ãžã®æž¡èªçŠæ¢ããçºä»€ããããšã«ãªã£ãã»ã©ã§ããã
ã€ã¹ã©ãšã«ä¿å¥çã¯ããã¡ã€ã¶ãŒã®ã¯ã¯ãã³ã®äºé²å¹æã¯39ïŒ ã«äœäžããŠããããšå ¬è¡šã
ããããŠãã¯ã¯ãã³ã®ãã«ã¿æ ªãžã®éçåäºé²å¹æãšããææç ãžã®æ
å ±é瀺ã«é¢ããŠãææããŠããªãããšé瀺ãæåŠã
ããã«å¯ŸããŠäžçŽæ©é¢ã§ããååŽçã«å¯©æ»è«æ±ãããããã§ãã
審æ»è«æ±ãšã¯ãæ
å ±é瀺ã®äžé瀺ãªã©ã«å¯ŸããŠç°è°ãç³ãç«ãŠãå¶åºŠã§ãã
æžãæ¹çã¯ãã®ãã€ãŒãæçš¿ã®ããã«æžããŸãã
審æ»è«æ±ãé 匵ã£ãŠãã ããã
â f.g sweet (@mysweetmoon1983) September 17, 2023
æ å ±é瀺ã§äžåœã ãšæã£ãããäžèšã®ãããªæ§åŒã§ã審æ»è«æ±ãããããšãã§ããŸã
蚎èšã«æ¯ã¹ãã°ãè² æ ãå°ãªãè¡æ¿ã«ææžã®é瀺ã®åŠ¥åœæ§ãåããã®ã§ãæ å ±çµ±å¶ãèµ·ãã£ãŠããä»å¿ èŠã§ããæéã¯äžå¹Žãšãã§ãããäžå¹ŽåŸäºæ ãå€ãã£ãŠããã°é瀺ããããããããªãã§ã https://t.co/YNA1Cw9ndB
ãã®ããã«ãææç ã®æ å ±é瀺ã«å¯ŸããŠååŽçãžå¯©æ»è«æ±ããããã§ããã審æ»è«æ±ã«å¯ŸããŠã¯ãéãããè¡æ¿åºãæèŠãéã£ãŠããã®ãæ®éã§ããããã§éããããååŽå€§è£ããã®è¿çã«åç¶ãšããŸããã
ä»¥äžæç²


ææç ã¯ãç¹å®ã®ã¯ã¯ãã³ãç¹å®ã® ãŠã€ã«ã¹æ ªã«å¯Ÿ ããŠå¹æã®æç¡ãæ€èšŒã ãèšåºè©Šéšãè¡ ãæ©é¢ã§ã¯ãªããããããã
ææç ã¯ãã¯ã¯ãã³ã®å¹æãåºãæ©é¢ã§ã¯ãªããããã«è³æçã¯ãªãã
ãïŒã€ã¹ã©ãšã«ã®ã¯ã¯ãã³å¹æãè«æã§äž»åŒµããŠãŸãããïŒãããæé æ°å³ã®ïŒ
ããããææç ã¯åç§äŒãšãã§ãã¯ã¯ãã³ã®å¹æã䞻匵ããŠãŸãããïŒ
ããããææç ã®é©ãã¹ãéæ³ã®å®æ
ã§ããã
ãç¬ç«è¡æ¿æ³äººå»è¬åå»çæ©åšç·åæ©æ§ïŒPMDAïŒã以å€ã¯åœã®ã¯ã¯ãã³å¹æãåºãæ©é¢ã§ã¯ãªãã®ã§ãå
¬åŒã«ã¯ã¯ã¯ãã³å¹æãæ¥åãšããŠåºãããããããšã¯æ¥åå€ã§éæ³ã«ãªãå¯èœæ§ããããŸãããã®æ
å ±é瀺ã ãšã¯ã¯ãã³å¹æã®è³æããªãã®ã«åæã«ã¯ã¯ãã³å¹æã®è«æãåºããŠããææç ã®éæ³æ¥åãæããã«ãªã£ãŠããããã§ãã
ååŽçã«ã¯ãã®ãããªéæ³æ¥åãåããŠã
ãè¬å®³ AIDS è£å€ã«ãããŠã¯ãè¬åè¡æ¿ã«ãããåœæ°ãžã®æ
å ±ã³ã³ãããŒã«ã¯ç¯çœªã§ããããšã瀺ãããŠããã
ææç ããç¹å®ã®ã¯ã¯ãã³ã®èšåºè©Šéšãè¡ãæ©é¢ã§ãªãããšãã䞻匵ããããšããŠããçŸå®çã«ãæ°åã³ããã¯ã¯ãã³ã«ã€ããŠ ïŒ 2021 幎 8 ✠5 âœçŸåš ïŒãææç çºè¡šã ãçºè¡šãã以äžããã®è«æã«ãããããŒã¿ã¯ä¿æããŠããªããã°ãªããªããšäž»åŒµãããä»®ã«ä¿æããŠããªããã°ãã¹ãŠãæé ã§ããããšã«ãªããææç ã®ç¯çœªæ§ã¯ç¢ºå®ãªãã®ã«ãªããã
ãšãéæ³ãã€ææç ã®ç¯çœªæ§ã®é«ãã¯ã¯ãã³æ¥åã«ããããååŽçã®èšãåã«å¯ŸããŠè¿ä¿¡ããŠããŸãããã®ããåãã2023幎6æã«è¡ãããææç ã¯éãã«ãªããŸããã
ã¯ã¯ãã³å¹æãåºãããšãéæ³æ¥åã§ããããšãã°ããŠé»ã£ãããã§ãã
ãã®æ å ±é瀺ã®å¯©æ»è«æ±ã¯ããŸã éäžçµéã§ãçµæã¯ãŸã åºãŠããŸããããææç ã®æŽèµ°ããåããããã ãããšæããŸãã
æ¬æ¥ãªããã¯ã¯ãã³å¹æãç¥ã£ãŠãããç¬ç«è¡æ¿æ³äººå»è¬åå»çæ©åšç·åæ©æ§ïŒPMDAïŒãããªã衚ç«ã£ãŠå¹æãçºè¡šããªãã®ãïŒ
ããã¯ãæ¬åœã®ããšãäŒãããšå¹æããªãå®å
šæ§ããªããããç¯çœªã«ãªãããã§ãããã
以äžãéäžçµéãªã®ã§ãŸã ä»åŸå€åã¯ãããããããŸããã
äºå¹Žéã«ãããææç ãšã®æŠãã®å ±åã§ããã